Home / Respiratory system / Budesonide
ATC R03BA02 · Glucocorticoids · updated 4 Nov 2026
Budesonide shortage
As of 4 Nov 2026, Budesonide has a reported shortage in 4 of the 16 countries we track (Canada, Germany, Belgium, Sweden), covering 9 products from 3 companies.
Is there a Budesonide shortage?
Yes. As of 4 Nov 2026, Budesonide is reported short in 4 of the 16 countries we track: Canada, Germany, Belgium, Sweden. The earliest expected return is 30 Nov 2026 (Sweden). 3 of 9 affected products have no return date. New since 5 Oct 2026: Sweden.
spreading How the shortage spread
All cross-border shortagesCountries in the order the shortage started there (earliest start date of a product still short). First reported in Canada on 14 Apr 2022; most recently in Sweden on 1 Nov 2026.
- CACanadasince 14 Apr 2022
- DEGermanysince 1 Aug 2025
- BEBelgiumsince 31 Dec 2025
- SESwedensince 1 Nov 2026
Not on the official list in: United States, France, Italy, Spain, Ireland, Austria, Switzerland, Czechia, Norway, Japan, New Zealand, Australia.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Sun Pharma SUNPHARMA · NSE, Teva TEVA · NYSE / TASE
Compared with similar medicines
ATC group R03BA · GlucocorticoidsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TARO-BUDESONIDE (2) | TARO PHARMACEUTICALS INC | 14 Apr 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TARO-BUDESONIDE (2) | TARO PHARMACEUTICALS INC | 14 Apr 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TARO-BUDESONIDE (20 x 2 Suspension) | TARO PHARMACEUTICALS INC | 11 Jun 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| DE | Cyclocaps Budesonid 200 µg | PB Pharma GmbH | 1 Aug 2025 | 31 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Cyclocaps Budesonid 200 µg | PB Pharma GmbH | 1 Aug 2025 | 31 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Cyclocaps Budesonid 200 µg | PB Pharma GmbH | 1 Aug 2025 | 31 Dec 2026 | Increased demand Erhöhte Nachfrage |
| BE | Budesonide Teva 0.5 mg/ml nebul. susp. amp. 60 x 2 ml | Teva | 31 Dec 2025 | 11 Jan 2027 | Manufacturing problem Delay in production |
| SE | Budesonide Teva Pharma 0,25 mg/ml Endosbehållare, 20 x 2 ml | Teva Pharma BV | 1 Nov 2026 | 30 Nov 2026 | Not stated |
| SE | Budesonide Teva Pharma 0,125 mg/ml Endosbehållare, 20 x 2 ml anticipated | Teva Pharma BV | 10 Nov 2026 | 15 Jan 2027 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Budesonide shortage?
Yes. As of 4 Nov 2026, Budesonide is reported short in 4 of the 16 countries we track: Canada, Germany, Belgium, Sweden. The earliest expected return is 30 Nov 2026 (Sweden). 3 of 9 affected products have no return date. New since 5 Oct 2026: Sweden.
When will Budesonide be back in stock?
Companies expect supply back from 30 Nov 2026 in Sweden; Canada: no date given; Germany: 31 Dec 2026; Belgium: 11 Jan 2027; Sweden: 30 Nov 2026. These are company estimates reported to each authority.
Why is Budesonide in short supply?
The most common reason reported is: manufacturing problem. Reasons by product are listed in the table below.
Which companies have Budesonide shortages?
Sun Pharma, Pb, Teva.